D-dimer
D-dimer[edit]

D-dimer is a fibrin degradation product (or FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. It is named because it contains two D fragments of the fibrin protein joined by a cross-link. D-dimer concentration may be determined by a blood test to help diagnose thrombosis.
Clinical significance[edit]
D-dimer is a significant marker in the diagnosis of thrombotic disorders. It is used primarily to exclude the presence of an inappropriate blood clot (thrombus). A negative D-dimer test indicates that it is highly unlikely that a thrombus is present. Conversely, a positive D-dimer test is not specific and does not confirm the presence of a thrombus, as D-dimer levels can be elevated in other conditions such as inflammation, infection, or liver disease.
Diagnostic use[edit]
The D-dimer test is commonly used in the diagnosis of deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). It is particularly useful in emergency settings to rule out thromboembolic events in patients with low to moderate risk.
Pathophysiology[edit]
D-dimer is formed by the action of plasmin on cross-linked fibrin. When a blood clot is formed, the coagulation cascade is activated, leading to the conversion of fibrinogen to fibrin. Fibrin forms a mesh that stabilizes the clot. Plasmin, an enzyme, breaks down the fibrin mesh, resulting in the release of D-dimer into the bloodstream.
Testing[edit]
D-dimer levels are measured using a blood test. The test is often performed using an enzyme-linked immunosorbent assay (ELISA) or a latex agglutination test. The results are typically reported in fibrinogen equivalent units (FEU) or D-dimer units (DDU).
Limitations[edit]
While the D-dimer test is a useful tool for ruling out thrombotic events, it has limitations. Elevated D-dimer levels can occur in a variety of conditions, including pregnancy, trauma, surgery, and cancer. Therefore, a positive D-dimer test must be interpreted in the context of the patient's clinical presentation and risk factors.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian